Channel permeant cations compete selectively with noncompetitive inhibitors of the nicotinic acetylcholine receptor.
Previous work suggests that noncompetitive inhibitor (NCI) ligands and channel permeant cations bind to sites within the nicotinic acetylcholine receptor ion channel. We have used ethidium as a fluorescent probe of the NCI site to investigate interactions between NCI ligands and channel permeant cations. We found that ethidium can be completely displaced from the receptor by a variety of inorganic monovalent and divalent cations. The rank order of monovalent cation affinities was found to be Tl+ greater than Rb+ greater than or equal to K+ greater than Cs+ greater than Na+ greater than Li+. The monovalent cation Kd values vary markedly over a 40-fold range, from 3 to 121 mM. The Kd values and rank order correspond to values determined previously from electrophysiological data. Hill plots of the back titrations yield slopes of 1.0 for all monovalent cations, indicating a single class of independent sites, as shown previously for NCI ligands. Scatchard analysis of ethidium binding in the presence of Tl+ reveals a reduction in affinity and no changes in the maximal number of sites. In the presence of agonist the kinetics of ethidium dissociation induced by the addition of phencyclidine or cations alone or the simultaneous addition of both are nearly identical. The ethidium dissociation rate induced by either phencyclidine or cations is regulated by the occupation of the agonist sites in a similar manner. These results indicate that the effect of cations on NCI ligand binding occurs by mutually exclusive competition. We suggest that NCIs can regulate cation binding at a physiological cation recognition site that is likely part of the cation permeation path through the receptor channel.
Herz
J M
JM
Institute for Neuroscience, University of Texas, Austin 78713.
Kolb
S J
SJ
Erlinger
T
T
Schmid
E
E
D000818:Animals; D001667:Binding, Competitive; D002412:Cations / Q000378:metabolism; D004996:Ethidium / Q000378:metabolism; D007473:Ion Channels / Q000378:metabolism*; D007700:Kinetics; D018733:Nicotinic Antagonists; D010622:Phencyclidine / Q000494:pharmacology; D014101:Torpedo
D002412:Cations; D007473:Ion Channels; D018733:Nicotinic Antagonists; D004996:Ethidium; D010622:Phencyclidine